Inpatient Solid Tumor / Neuro-Oncology Rotation

    During this rotation the resident will be responsible for medication therapy management of patients with solid and central nervous system malignancies. The resident will learn about the front line clinical trials for newly-diagnosed neuroblastoma, rhabomyosarcoma, osteosarcoma, Ewing family of sarcomas, Wilms tumor and medulloblastoma. Management of the service includes research and clinical pharmacokinetic consults, management of metabolic support, pain management / palliative care, drug information, patient education, discharge planning and medication reconciliation and maintenance of allergy and adverse drug event database.